| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023127 |
| Receipt No. | R000026659 |
| Official scientific title of the study | Quality of Systematic Reviews Underlying Clinical Practice Guidelines |
| Date of disclosure of the study information | 2016/08/01 |
| Last modified on | 2016/08/02 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Quality of Systematic Reviews Underlying Clinical Practice Guidelines
|
|
| Title of the study (Brief title) | Quality of Systematic Reviews underlying Clinical Practice Guidelines for Pediatric Obesity
|
|
| Region |
|
|
| Condition | ||
| Condition | Methodological Quality and completeness of reporting as represented by the AMSTAR tool and PRISMA checklist.
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to assess the methodological quality and completeness of reporting in Systematic Reviews including pediatric patients and underlying current Clinical Practice Guidelines for Obesity across domestic professional organizations both.
|
| Basic objectives2 | Others |
| Basic objectives -Others | To assess the methodological quality and completeness of reporting in Systematic Reviews underlying Clinical Practice Guidelines for Pediatric Obesity.
|
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Global Methodological Quality and Completeness of Reporting of Clinical Practice Guidelines as represented by underlying systematic reviews graded with the AMSTAR tool and PRISMA checklist, respectively. |
| Key secondary outcomes | Comparing the extent to which United States and international groups use available, relevant systematic reviews to formulate guidelines. |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Clinical Practice Guidelines:
1. Clinical Practice Guidelines must be recognized by a national governmental or provider/professional organization. 2. Clinical Practice Guidelines must be in English. 3. Clinical Practice Guidelines must contain recommendations relevant to best practices in the diagnosis, treatment, and/or management of Obesity in pediatric populations. Systematic Reviews: 1. Systematic Reviews must be in English. 2. Systematic Reviews must be peer-reviewed and published, or currently in press. 3. The Systematic Review must have performed a systematic search and synthesis of available evidence. 4. The Systematic Review includes, at least in part, a synthesis of data from pediatric populations |
|||
| Key exclusion criteria | Clinical Practice Guidelines:
1. Clinical Practice Guidelines without reference lists and those without readily accessible reference lists such as those only accessible by email correspondence will be excluded. 2. Addendums published relevant to one or more recommendations for a CPG will be excluded. 3. CPGs not recognized by a professional organization or governmental body will be excluded. Systematic Reviews: 1. Systematic reviews of animal studies will be excluded. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Matt Vassar |
| Organization | Oklahoma State University Center for Health Sciences |
| Division name | College of Osteopathic Medicine |
| Address | 1111 W. 17th St. |
| TEL | 918-582-1972 |
| matt.vassar@okstate.edu | |
| Public contact | |
| Name of contact person | Matt Vassar |
| Organization | Oklahoma State University Center for Health Sciences |
| Division name | College of Osteopathic Medicine |
| Address | 1111 W. 17th St. |
| TEL | 918-582-1972 |
| Homepage URL | http://www.healthsciences.okstate.edu |
| matt.vassar@okstate.edu | |
| Sponsor | |
| Institute | Oklahoma State University Center for Health Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Oklahoma State University Center for Health Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | No other related information |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026659 |